Stay updated on Dupilumab Efficacy in Pediatric EoE Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in Pediatric EoE Clinical Trial page.

Latest updates to the Dupilumab Efficacy in Pediatric EoE Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now renders a 403 Forbidden error for the study record, signaling that access is denied. This reflects an access-control issue rather than a content update to the study data or page layout.SummaryDifference23%

- Check43 days agoChange DetectedA funding note was added (2019 U.S. NIH Grant/Contract) and the revision version updated from v3.6.5 to v3.6.6, reflected in the page metadata.SummaryDifference0.1%

- Check57 days agoChange DetectedA new bibliographic citation for a Dupilumab transcriptome study was added to the Publications section. The previously listed online-ahead-of-print citation was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 to reflect a system update. It does not imply changes to the study content or its presentation.SummaryDifference0.0%

- Check79 days agoChange DetectedA new publication reference on dupilumab pharmacokinetics in EoE across age groups was added to Publications, and the page revision version was updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

Stay in the know with updates to Dupilumab Efficacy in Pediatric EoE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in Pediatric EoE Clinical Trial page.